Cargando…
Gene therapy for lipid disorders
Lipid disorders are associated with atherosclerotic vascular disease, and therapy is associated with a substantial reduction in cardiovascular events. Current approaches to the treatment of lipid disorders are ineffective in a substantial number of patients. New therapies for refractory hypercholest...
Autores principales: | Kawashiri, Masa-aki, Rader, Daniel J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59613/ https://www.ncbi.nlm.nih.gov/pubmed/11714424 http://dx.doi.org/10.1186/cvm-1-2-120 |
Ejemplares similares
-
Statin Intolerance and Suboptimal Statin Therapy
por: Tada, Hayato, et al.
Publicado: (2019) -
Can PCSK7 be A New Pharmaceutical Target?
por: Kawashiri, Masa-aki
Publicado: (2022) -
Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies
por: Tada, Hayato, et al.
Publicado: (2018) -
Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease
por: Tada, Hayato, et al.
Publicado: (2019) -
Clinical Perspectives of Genetic Analyses on Dyslipidemia and Coronary Artery Disease
por: Tada, Hayato, et al.
Publicado: (2017)